News
Medtronic opens up about Elon Musk and SpaceX’s role in fight against COVID-19
Earlier this year, Elon Musk announced on Twitter that SpaceX would be working with medical device firm Medtronic to help the company produce its most advanced ventilators, which are pivotal in the battle against the pandemic. Details about the two companies’ collaboration have been quite slim since then, with Musk simply noting that SpaceX was producing valves for Medtronic.
In a recent post, Medtronic opted to share some key insights about its work with Elon Musk and his private space enterprise. The medical device maker’s story highlighted the value of Musk’s Silicon Valley-style approach to his companies, which emphasizes quick innovation that’s directed towards the development of real-world, practical solutions in the shortest time possible.
Medtronic’s Puritan Bennett 980 Ventilator Series is the company’s most advanced ventilator. It allows patients to breathe naturally through a series of innovative breath delivery technologies. It’s also fitted with a unique ventilator assistance feature that allows the machine to continue delivering ventilatory support even in the event of certain system failures. The flagship machine is built in Medtronic’s facility in Galway, Ireland, and it has become a staple in numerous hospitals.
In a typical year, Medtronic’s Galway plant could produce about 7,500 valves for its flagship ventilator. But with COVID-19 spreading across the globe, the need for ventilators increased rapidly and significantly. Medtronic promptly increased the production of its ventilators, and by mid-March, the Galway plant had raised its output by 40%. But it was not enough. Building ventilators is a complex process, after all, and the machines require advanced components that are difficult to manufacture.
One of these components is a proportional solenoid (PSOL) valve, a highly complex piece of machinery that controls the flow of air and oxygen inside the machine. The PSOL valve consists of over 50 parts, and each must be manufactured with surgical precision, with some components having tolerances as thin as a strand of hair. Medtronic’s most advanced ventilator used three of these PSOL valves per unit, and as noted by Medtronic Engineer Matt Phillips, the medical device firm was pretty much at a loss about how it could meet the increasing demand for its products.
And then Elon Musk called, and he came with a unique, interesting proposal.
Musk’s private space firm, SpaceX, which made its mark in the industry with its reusable rockets and its Crew Dragon spacecraft, offered to make PSOL valves for Medtronic. SpaceX proved to be the perfect partner for the medical device maker, as it already had a division that designs and manufactures valves for its rockets. The private space enterprise’s engineers were top-notch, and they had the technical expertise to stand up to the challenge. And with that, the two companies’ collaboration began.
In a display of its quick, Silicon Valley-style approach to problem-solving, SpaceX did not waste any time. COVID-19 was not letting up, and neither was Elon Musk’s private space enterprise. SpaceX promptly converted part of its rocket factory in Hawthorne, California to produce PSOL valves with the help of Medtronic employees. To maximize mobility and speed, the team even built a PSOL valve manufacturing line on carts. Ultimately, the SpaceX and Medtronic team achieved in months what might have otherwise taken years.
“They literally turned a rocket production area into a ventilator valve manufacturing facility almost overnight,” Phillips said.
As noted by the Medtronics engineer, SpaceX did not scrimp on its talent, with some of the engineers who worked on the Crew Dragon capsule working on the Medtronic project. Quality control was extremely high, with the valves produced at the SpaceX site undergoing rigorous testing before being shipped to Galway.
“We had their best technicians. We had their best engineers. Some of the people working on this project are the very people who just launched the first private commercial crew to the International Space Station. They brought the same kind of energy to this project that they brought to putting astronauts into space,” Phillips noted.
“When it comes down to it, these ventilators are going to save lives,” Phillips said. “So every component has to be perfect. There is no room for error, which is why we put these valves through such an intensive testing protocol,” the Medtronic engineer added.
Thanks in no small part to the quick initiative of the SpaceX team, the medical equipment company now has the capability to produce 9,000 PSOL valves for Medtronic’s flagship ventilator over the next 8 to 10 weeks. That’s about the same amount of valves that Medtronic’s Galway plant produced in 2019. The Galway facility, for its part, could now operate at five times the volume of its pre-pandemic operations.
“I have never seen anything like this in my life… This project certainly changed the way I look at production, partnership, and innovation. I know that, with the right focus and the right energy, we can take what we learned from this project and apply it to other challenges that come our way,” Phillips remarked.
Elon Musk
SpaceX issues statement on Starship V3 Booster 18 anomaly
The incident unfolded during gas-system pressure testing at the company’s Massey facility in Starbase, Texas.
SpaceX has issued an initial statement about Starship Booster 18’s anomaly early Friday. The incident unfolded during gas-system pressure testing at the company’s Massey facility in Starbase, Texas.
SpaceX’s initial comment
As per SpaceX in a post on its official account on social media platform X, Booster 18 was undergoing gas system pressure tests when the anomaly happened. Despite the nature of the incident, the company emphasized that no propellant was loaded, no engines were installed, and personnel were kept at a safe distance from the booster, resulting in zero injuries.
“Booster 18 suffered an anomaly during gas system pressure testing that we were conducting in advance of structural proof testing. No propellant was on the vehicle, and engines were not yet installed. The teams need time to investigate before we are confident of the cause. No one was injured as we maintain a safe distance for personnel during this type of testing. The site remains clear and we are working plans to safely reenter the site,” SpaceX wrote in its post on X.
Incident and aftermath
Livestream footage from LabPadre showed Booster 18’s lower half crumpling around the liquid oxygen tank area at approximately 4:04 a.m. CT. Subsequent images posted by on-site observers revealed extensive deformation across the booster’s lower structure. Needless to say, spaceflight observers have noted that Booster 18 would likely be a complete loss due to its anomaly.
Booster 18 had rolled out only a day earlier and was one of the first vehicles in the Starship V3 program. The V3 series incorporates structural reinforcements and reliability upgrades intended to prepare Starship for rapid-reuse testing and eventual tower-catch operations. Elon Musk has been optimistic about Starship V3, previously noting on X that the spacecraft might be able to complete initial missions to Mars.
Investor's Corner
Tesla analyst maintains $500 PT, says FSD drives better than humans now
The team also met with Tesla leaders for more than an hour to discuss autonomy, chip development, and upcoming deployment plans.
Tesla (NASDAQ:TSLA) received fresh support from Piper Sandler this week after analysts toured the Fremont Factory and tested the company’s latest Full Self-Driving software. The firm reaffirmed its $500 price target, stating that FSD V14 delivered a notably smooth robotaxi demonstration and may already perform at levels comparable to, if not better than, average human drivers.
The team also met with Tesla leaders for more than an hour to discuss autonomy, chip development, and upcoming deployment plans.
Analysts highlight autonomy progress
During more than 75 minutes of focused discussions, analysts reportedly focused on FSD v14’s updates. Piper Sandler’s team pointed to meaningful strides in perception, object handling, and overall ride smoothness during the robotaxi demo.
The visit also included discussions on updates to Tesla’s in-house chip initiatives, its Optimus program, and the growth of the company’s battery storage business. Analysts noted that Tesla continues refining cost structures and capital expenditure expectations, which are key elements in future margin recovery, as noted in a Yahoo Finance report.
Analyst Alexander Potter noted that “we think FSD is a truly impressive product that is (probably) already better at driving than the average American.” This conclusion was strengthened by what he described as a “flawless robotaxi ride to the hotel.”
Street targets diverge on TSLA
While Piper Sandler stands by its $500 target, it is not the highest estimate on the Street. Wedbush, for one, has a $600 per share price target for TSLA stock.
Other institutions have also weighed in on TSLA stock as of late. HSBC reiterated a Reduce rating with a $131 target, citing a gap between earnings fundamentals and the company’s market value. By contrast, TD Cowen maintained a Buy rating and a $509 target, pointing to strong autonomous driving demonstrations in Austin and the pace of software-driven improvements.
Stifel analysts also lifted their price target for Tesla to $508 per share over the company’s ongoing robotaxi and FSD programs.
Elon Musk
SpaceX Starship Version 3 booster crumples in early testing
Photos of the incident’s aftermath suggest that Booster 18 will likely be retired.
SpaceX’s new Starship first-stage booster, Booster 18, suffered major damage early Friday during its first round of testing in Starbase, Texas, just one day after rolling out of the factory.
Based on videos of the incident, the lower section of the rocket booster appeared to crumple during a pressurization test. Photos of the incident’s aftermath suggest that Booster 18 will likely be retired.
Booster test failure
SpaceX began structural and propellant-system verification tests on Booster 18 Thursday night at the Massey’s Test Site, only a few miles from Starbase’s production facilities, as noted in an Ars Technica report. At 4:04 a.m. CT on Friday, a livestream from LabPadre Space captured the booster’s lower half experiencing a sudden destructive event around its liquid oxygen tank section. Post-incident images, shared on X by @StarshipGazer, showed notable deformation in the booster’s lower structure.
Neither SpaceX nor Elon Musk had commented as of Friday morning, but the vehicle’s condition suggests it is likely a complete loss. This is quite unfortunate, as Booster 18 is already part of the Starship V3 program, which includes design fixes and upgrades intended to improve reliability. While SpaceX maintains a rather rapid Starship production line in Starbase, Booster 18 was generally expected to validate the improvements implemented in the V3 program.
Tight deadlines
SpaceX needs Starship boosters and upper stages to begin demonstrating rapid reuse, tower catches, and early operational Starlink missions over the next two years. More critically, NASA’s Artemis program depends on an on-orbit refueling test in the second half of 2026, a requirement for the vehicle’s expected crewed lunar landing around 2028.
While SpaceX is known for diagnosing failures quickly and returning to testing at unmatched speed, losing the newest-generation booster at the very start of its campaign highlights the immense challenge involved in scaling Starship into a reliable, high-cadence launch system. SpaceX, however, is known for getting things done quickly, so it would not be a surprise if the company manages to figure out what happened to Booster 18 in the near future.
SpaceX issues statement on Starship V3 Booster 18 anomaly
Tesla analyst maintains $500 PT, says FSD drives better than humans now
